PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 47 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,657,000 | +5.7% | 194,969 | +5.0% | 0.01% | 0.0% |
| Q1 2020 | $11,024,000 | -25.2% | 185,656 | -31.0% | 0.01% | -16.7% |
| Q4 2019 | $14,731,000 | +94.0% | 268,921 | +0.0% | 0.01% | +100.0% |
| Q3 2019 | $7,592,000 | -15.2% | 268,839 | -0.4% | 0.00% | -25.0% |
| Q2 2019 | $8,956,000 | +14.4% | 269,850 | +17.2% | 0.00% | +33.3% |
| Q1 2019 | $7,829,000 | +24.1% | 230,256 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $6,311,000 | -4.2% | 230,406 | +2.1% | 0.00% | 0.0% |
| Q3 2018 | $6,591,000 | – | 225,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,625,713 | $76,723,000 | 13.96% |
| Sofinnova Investments, Inc. | 2,059,146 | $59,556,000 | 5.31% |
| Cormorant Asset Management, LP | 1,486,898 | $43,447,000 | 2.82% |
| RTW INVESTMENTS, LP | 644,448 | $17,369,000 | 1.04% |
| Orbimed Advisors | 2,605,713 | $76,139,000 | 0.92% |
| BVF INC/IL | 240,000 | $7,013,000 | 0.62% |
| Monashee Investment Management LLC | 62,500 | $1,826,000 | 0.39% |
| DC Investments Management, LLC | 18,376 | $537,000 | 0.36% |
| Baker Brothers Advisors | 1,787,807 | $52,240,000 | 0.34% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 248,626 | $7,265,000 | 0.22% |